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The Role of Lysosomal Cysteine Proteinases as Markers 
of Macrophage Activation and as Nonspecific Mediators 
of Inflammation 
W . M a c h l e i d t 1 , I . Assfalg-Machleidt 1 , A. B i l l i n g 2 , D . F r ö h l i c h 2 , Μ . Jochum 3 , 
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Introduction 
A major p o r t i o n of the lysosomal proteinases responsible for intracellular 
degradat ion of phagocytized proteins are cysteine proteinases, the "acid" cath-
epsins Β, H , L , and S (see [ 1 ] for review). As we have shown previously [ 2 , 3 ] , 
increased cysteine proteinase act ivi ty is found in b lood plasma of polyt rauma-
tized and septic patients as well as i n local inf lammatory secretions such as 
bronchoalveolar lavage fluid and peri tonit is exudate. M o s t of this act ivi ty is due 
to cathepsin B, which is relatively stable at neutral p H (half-life about 30 m i n at 
p H 7.4) and is protected in the fo rm of reversible complexes w i th its en-
dogenenous protein inhibi tors (stefins, cystatins, and kininogens). Here we 
report some evidence for the role of cathepsin Β as a marker of macrophage 
ac t iva t ion and of lysosomal cysteine proteinases as potential nonspecific medi­
ators of inf lammat ion. 
Materials and Methods 
Cysteine proteinase act ivi ty and complexed polymorphonuclear ( P M N ) elastase 
were determined by f luorometric assay and enzyme-linked immunosorbent 
assay as described [2 , 3 ] . The organizat ion of cl inical studies and sampling 
protocols were reported i n detail elsewhere [4 , 5 ] . Proteolysis of fluorescein 
isothiocyanate I g G (Sigma) by human cathepsin Β (Medor , Herrsching, F R G ) 
and peri toni t is exudate was performed as described [ 6 ] . 
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Results and Discussion 
Cathepsin Β as Marker of Macrophage Activation. P M N granulocytes contain 
only minute amounts of cathepsin Β (1.5 ng /10 6 cells), whereas high levels of 
cathepsin B, L , and Η have been found in monocytes, macrophages, and other 
cells of the reticuloendothelial system [3 , 7, 8 ] . Therefore cathepsin Β may be 
considered as a marker for the activi ty of the monocyte/macrophage system. 
This hypothesis was supported by different patterns of release of cathepsin Β 
and P M N elastase dur ing inf lammat ion in patients. 
Cathepsin Β of b lood plasma after major t rauma reaches its m a x i m u m at 
least 6 h earlier than complexed P M N elastase (Fig. 1). This early cathepsin Β 
activi ty of b lood plasma proved to be a sensitive and specific parameter for the 
predict ion of subsequent mul t ip le organ failure (Nas t -Ko lb et al., this volume). 
I n al l groups of patients, cathepsin Β activity returned to only slightly elevated 
levels w i t h i n 3 days after the trauma. Early cathepsin Β act ivi ty does not 
discriminate between lethal and reversible organ failure. A nearly constant 
elastase/cathepsin Β rat io around 300 was observed dur ing the first 3 days in all 
patients, followed by a slow decrease in the groups wi th reversible organ failure 
and wi thou t organ complications. I n patients developing lethal organ failure the 
elastase/cathepsin Β ratio increased to 500-600 and remained high after the 3rd 
day (Fig. 2). 
As determined wi th cell lysates, an elastase/cathepsin Β rat io of 3000-6000 
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Fig. 1. Cathepsin Β activity ( · ) and complexed PMN elastase ( Δ ) of blood plasma in the early 
phase after major trauma. Both enzymes were expressed as multiples of their normal values 
(50 mU/I for cathepsin B, 90 ng/ml for PMN elastase). Mean values ± S E M of 29 patients without 
organ complications ( ) and 29 patients with reversible multiple organ failure ( ) 
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Fig. 2. Elastase/cathepsin Β ratio in blood plasma of patients after severe multiple injury. Mean 
values ± S E M for 29 patients without organ complications (Ο), 29 patients with reversible multiple 
organ failure (A), and 11 patients with lethal multiple organ failure ( • ) 
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Fig. 3. Elastase/cathepsin Β ratio in peritonitis exudates {n = 166). Cumulative percentage of 
samples as a function of increasing elastase/cathepsin Β ratio. Shaded area, range of elastase/cathep­
sin Β ratios found within lysates of PMN granulocytes from healthy persons 
This rat io was indeed found i n a few peritonitis exudates containing high 
numbers of neutrophils (Fig. 3). I n the major i ty of samples, however, much 
lower elastase/cathepsin Β ratios were observed, support ing the or ig in of 
cathepsin Β from cells other than neutrophils. Elastase/cathepsin Β ratios close 
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Fig. 4. Degradation of immunoglobulin G (IgG) by isolated human cathepsin Β and by E-64 
sensitive proteinase activity in peritonitis exudate. Fast gel chromatography of fluorescein isothio-
cyanate labeled IgG and its fragments on a Superose 12 column 
to 1 were found in bronchoalveolar lavage f luid conta ining a large number o f 
alveolar macrophages. 
Cysteine Proteinases as Nonspecific Mediators of Inflammation. Direct evidence 
for a role of cysteine proteinases in proteolyt ic pathomechanisms of inf lamma­
t ion comes from studies wi th peri tonit is exudates. Peritonitis exudates reveal 
strong proteolyt ic act ivi ty which is paralleled by deficient opsonic capacity and 
high levels of the lysosomal proteinases P M N elastase and cathepsin Β [ 6 ] . 
Using fluorescence-labeled protein, degradation of I g G by cell-free supernatant 
of peritonitis exudate was demonstrated in v i t ro (Fig. 4). Part of this degrada­
t ion can be prevented by addi t ion of E-64, a specific inact ivator of cysteine 
proteinases, indicat ing that lysosomal cysteine proteinases are involved. Cata­
lytic amounts of isolated human cathepsin Β (see Fig . 4) and L are able to 
Proteolyse I g G in v i t ro effectively. 
Conclusions 
Cathepsin Β seems to be a useful marker for the act ivi ty o f phagocytes of the 
monocyte/macrophage system that can be fol lowed easily i n b lood plasma and 
inflammatory secretions of patients. The observed very early release of cathepsin 
Β after blunt major injury raises new questions about the role of macrophages in 
the reaction sequence of the inf lammatory process. 
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Cysteine proteinases of monocytes/macrophages may play a role as non­
specific mediators of inf lammat ion comparable to that of the serine proteinases 
elastase and cathepsin G from P M N granulocytes. 
Acknowledgements. We wish to thank Prof. Hans Fritz, Munich, for stimulating discussion and 
generous support. The expert technical assistance of Mrs. Gerda Behrens and Mrs. Rita Zauner is 
greatly appreciated. The investigations were supported by the Sonderforschungsbereich 207 of the 
University of Munich. 
References 
1. Barett AJ, Buttle DJ, Mason RW (1988) Lysosomal cysteine proteinases. In: ISI atlas of science: 
biochemistry. Institute for Scientific information, Philadelphia, pp 256-2ό0 
2. Assfalg-Machleidt I, Jochum M, Klaubert W, Inthorn D, Machleidt W (1988) Enzymatically 
active cathepsin Β dissociating from its inhibitor complexes is elevated in blood plasma of 
patients with septic shock and some malignant tumors. Biol Chem Hoppe Seyler 369 [Suppl]: 
263-269 
3. Assfalg-Machleidt I, Jochum M, Nast-Kolb D, Siebeck M, Bulling A, Joka T. Rothe G, Valet G, 
Zauner R, Scheuber HP, Machleidt W (1990) Cathepsin Β —indicator for the release of lysosomal 
cysteine proteinases in severe trauma and inflammation. Biol Chem Hoppe Seyler 371 [Suppl]: 
211-222 
4. Nast-Kolb D, Waydhas C, Jochum M, Spannagl M, Duswald K H , Schweiberer L (1990) 
Günstigster Operationszeilpunkt für die Versorgung von Femurschaftfrakturen bei Polytrauma. 
Chirurg 61:259-265 
5. Billing Α, Fröhlich D, Kortmann H, Jochum Μ (1989) Die Insuffizienz der inlraabdominellen 
Infeklabwehr bei eitrigen Peritonitis—Folge einer gestörten Fremdkörperopsonierung. Klin 
Wochenschr 67:349-356 
6. Billing Α, Fröhlich D, Assfalg-Machleidt I, Machleidt W, Jochum Μ (1991) Proteolysis of 
defensive proteins in peritonitis exudate: pathobiochemical aspects and therapeutical approach. 
Biomed Biochim Acta 50:399-402 
7. Kominami E , Tsukahara T, Bando Y, Katunuma Ν (1985) Distribution of cathepsins Β and Η in 
rat tissues and peripheral blood cells. J Biochem 98:87-93 
8. Howie AJ, Burnett D, Crocker J (1985) The distribution of cathepsin Β in human tissues. J Pathol 
145:307-314 
